General Information of the Compound
Compound ID
CP0571673
Compound Name
3-[4-[4-(3-methoxyphenyl)piperazin-1-yl]butyl]-1,3-benzoxazine-2,4-dione
    Show/Hide
Formula
C23H27N3O4
Molecular Weight
409.486
Canonical SMILES
COc1cccc(c1)N1CCN(CCCCn2c(=O)oc3ccccc3c2=O)CC1
    Show/Hide
InChI
InChI=1S/C23H27N3O4/c1-29-19-8-6-7-18(17-19)25-15-13-24(14-16-25)11-4-5-12-26-22(27)20-9-2-3-10-21(20)30-23(26)28/h2-3,6-10,17H,4-5,11-16H2,1H3
    Show/Hide
InChIKey
UWQPVHXTQFWYAT-UHFFFAOYSA-N
Physicochemical Property
logP
2.5657
Rotatable Bonds
7
Heavy Atom Count
30
Polar Areas
67.92
Hydrogen Bond Donor Count
0
Hydrogen Bond Acceptor Count
7
Complexity
30

"RO5" indicates the cutoff set by lipinski's rule of five:

(1) Molecular weight less than 500 Dalton;

(2) xlogp less than 5;

(3) No more than 5 hbonddonor (Hydrogen Bond Donor Count);

(4) No more than 10 hbondacc (Hydrogen Bond Acceptor Count);

(5) No more than 10 rotbonds (Rotatable Bond Count).

    Show/Hide
Click to Show/Hide the External Link(s) of This Compound
ChEMBL ID
CHEMBL4875803
Map of Molecular Bioactivity Related to the Compound
Map of Molecular Bioactivity Related to the Compound

Compound
Cell Line
Protein

Bioactivity Value:

<= 0.1 μM
> 0.1 μM and <= 10 μM
> 10 μM
Imprecise Activity
Table of Molecular Bioactivities Related to the Compound
Protein ID: PT00819, 5-hydroxytryptamine receptor 1A
Cell-based Assay
Cell Line ID Cell Line Name Cell Line Organism
CL000006 HEK293 Homo sapiens (Human)  1
1
Ki = 3.2 nM
   TI
   LI
   LO
   TS